SCHEMBL747153

SCHEMBL747153

O=C1CCSCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22658159 0.84 — —
SCHEMBL10101158 0.78 CRBN (0.53) —
SCHEMBL4240098 0.76 — —
SCHEMBL18396750 0.72 — —
Thiazolidine SCHEMBL8794184 0.72 CRBN (0.52) —
SCHEMBL57039 0.71 — —
SCHEMBL27475685 0.69 — —
SCHEMBL27471834 0.69 — —
SCHEMBL1593092 0.69 — —
2-Pyrrolidone SCHEMBL27529551 0.67 OR51E2 (0.62) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1706147-A2 COMBINATION THERAPY WITH 5-HT sb 1A /sb AND 5-HT sb 1B /sb RECEPTOR ANTAGONISTS Recordati Ireland Limited (IE) 2006-10-04 — — EP claimed
WO-2005070460-A2 COMBINATION THERAPY WITH 5-HT1A AND 5-HT1B RECEPTOR ANTAGONISTS RECORDATI IRELAND LIMITED (IE) 2005-08-04 — — WO claimed
WO-2023190015-A1 1-ARYL TETRAHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE OR SALT THEREOF, PESTICIDE CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME 日本農薬株式会社 2023-10-05 — — WO disclosed
WO-2014169845-A2 4,5-DIHYDRO-PYRAZOLO [3, 4-C] PYRID-2-ONES, PREPARATION METHOD AND APPLICATION THEREOF 四川海思科制药有限公司 (CN) 2014-10-23 — — WO disclosed
US-20130338367-A1 PYRAZOLE DERIVATIVES AND PESTICIDES NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-12-19 — — US disclosed
EP-2674423-A1 PYRAZOLE DERIVATIVE AND PEST CONTROL AGENT Nissan Chemical Industries, Ltd. (JP) 2013-12-18 — — EP disclosed
US-20120088759-A1 THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD. (CH) 2012-04-12 — — US disclosed
US-20120088759-A1 THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD. (CH) 2012-04-12 — — US disclosed
CN-102413828-A Thiazolidin-4-one and [1,3] -thiazinan-4-one compounds as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD 2012-04-11 — — CN disclosed
CN-102413828-A Thiazolidin-4-one and [1,3] -thiazinan-4-one compounds as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD 2012-04-11 — — CN disclosed
EP-2429523-A1 THIAZOLIDIN-4-ONE AND [1,3]-THIAZINAN-4-ONE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2012-03-21 — — EP disclosed
US-6627627-B2 Useful as psychotherapeutic agents PFIZER INC. 2003-09-30 — — US disclosed
CN-1031570-C Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1996-04-17 — — CN disclosed
US-5155114-A Treating or preventing renal toxicity, nephrosis, nephritis FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-10-13 — — US disclosed
US-5098899-A Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites TRUSTEES OF BOSTON UNIVERSITY (US) 1992-03-24 — — US disclosed
US-4985444-A Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-01-15 — — US disclosed
EP-0379979-A1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-08-01 — — EP disclosed
EP-0236931-A2 Aromatic omega-alkylimino-tetrahydro-6H-1,3-Thiazin-6-one derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1987-09-16 — — EP disclosed
US-4301151-A OLIGOPEPTIDES CONTAINING A 1,3-THIAZIN-4-ONE RING OR A N-HETERO-4-ONE RINGS MERCK & CO., INC. (US) 1981-11-17 — — US disclosed
US-4254107-A Long-lasting agonists of enkephalin MERCK & CO., INC. (US) 1981-03-03 — — US disclosed
Send feedback